Martin Vogelbaum

Track

Insider profile

Currently holds a position at Cara Therapeutics Inc

Performance

Overall performance
2.0
Performance over holding periods
2.0
30 days 90 days 120 days
Average return 5% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
2 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Lead Independent Director Cara Therapeutics Inc July 1, 2010 -
Independent Director Rocket Pharmaceuticals Inc Jan. 1, 2014 - June 20, 2017
Director Rocket Pharmaceuticals Inc April 1, 2010 - Jan. 1, 2014
Martin Vogelbaum's trades of Cara Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Planned sale
Price
328.98
Quantity 80,333 +35.7%
Value US$463,136
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2022-09-16 2022-09-14
S Sale
41,347 -32.3%
396.34
US$4,653,616 		41,347 -32.3% 396.34 US$4,653,616
2021-06-07 2021-06-07
PlS Planned sale
80,333 +35.7%
328.98
US$463,136 		80,333 +35.7% 328.98 US$463,136
2020-11-19 2020-11-17
S Sale
3,903 +4.7%
100.19
US$3,743,178 		3,903 +4.7% 100.19 US$3,743,178